Cargando…

COVID19 therapeutics: Expanding the antiviral arsenal

Detalles Bibliográficos
Autor principal: Gallagher, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977477/
https://www.ncbi.nlm.nih.gov/pubmed/33752131
http://dx.doi.org/10.1016/j.ebiom.2021.103289
_version_ 1783667121749753856
author Gallagher, Tom
author_facet Gallagher, Tom
author_sort Gallagher, Tom
collection PubMed
description
format Online
Article
Text
id pubmed-7977477
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79774772021-03-19 COVID19 therapeutics: Expanding the antiviral arsenal Gallagher, Tom EBioMedicine Commentary Elsevier 2021-03-19 /pmc/articles/PMC7977477/ /pubmed/33752131 http://dx.doi.org/10.1016/j.ebiom.2021.103289 Text en © 2021 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Commentary
Gallagher, Tom
COVID19 therapeutics: Expanding the antiviral arsenal
title COVID19 therapeutics: Expanding the antiviral arsenal
title_full COVID19 therapeutics: Expanding the antiviral arsenal
title_fullStr COVID19 therapeutics: Expanding the antiviral arsenal
title_full_unstemmed COVID19 therapeutics: Expanding the antiviral arsenal
title_short COVID19 therapeutics: Expanding the antiviral arsenal
title_sort covid19 therapeutics: expanding the antiviral arsenal
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977477/
https://www.ncbi.nlm.nih.gov/pubmed/33752131
http://dx.doi.org/10.1016/j.ebiom.2021.103289
work_keys_str_mv AT gallaghertom covid19therapeuticsexpandingtheantiviralarsenal